(VIANEWS) – SELVAAG BOLIG (SBO.OL), SEADRILL (SDRL.OL), BW LPG (BWLPG.OL) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. SELVAAG BOLIG (SBO.OL)
124.7% sales growth and 10.32% return on equity
Selvaag Bolig ASA, a housing development company, engages in the development, construction, and sale of residential properties in Greater Oslo, Bergen, Stavanger, Trondheim, and Stockholm. The company also offers project management services. Selvaag Bolig ASA was incorporated in 2008 and is headquartered in Oslo, Norway. Selvaag Bolig ASA is a subsidiary of Selvaag AS.
Earnings Per Share
As for profitability, SELVAAG BOLIG has a trailing twelve months EPS of kr2.58.
PE Ratio
SELVAAG BOLIG has a trailing twelve months price to earnings ratio of 11.22. Meaning, the purchaser of the share is investing kr11.22 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.32%.
Moving Average
SELVAAG BOLIG’s value is below its 50-day moving average of kr32.05 and way under its 200-day moving average of kr33.00.
More news about SELVAAG BOLIG.
2. SEADRILL (SDRL.OL)
67.8% sales growth and 4.22% return on equity
Seadrill Limited provides offshore contract drilling services to the oil and gas industry worldwide. It operates in three segments: Harsh Environment, Floaters, and Jack-ups Rigs. The company owns and operates drill ships, semi-submersible rigs, and jack-up rigs for operations in shallow and ultra-deep-water in benign and harsh environments. It serves oil super-majors, state-owned national oil companies, and independent oil and gas companies. Seadrill Limited was formerly known as Seadrill 2021 Limited. The company was incorporated in 2005 and is headquartered in Hamilton, Bermuda.
Earnings Per Share
As for profitability, SEADRILL has a trailing twelve months EPS of kr664.63.
PE Ratio
SEADRILL has a trailing twelve months price to earnings ratio of 0.77. Meaning, the purchaser of the share is investing kr0.77 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.22%.
Sales Growth
SEADRILL’s sales growth is 60.9% for the present quarter and 67.8% for the next.
Volume
Today’s last reported volume for SEADRILL is 26212 which is 82.98% below its average volume of 154093.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is 374.2% and 272.9%, respectively.
Yearly Top and Bottom Value
SEADRILL’s stock is valued at kr513.00 at 22:20 EST, under its 52-week high of kr537.00 and way higher than its 52-week low of kr228.00.
More news about SEADRILL.
3. BW LPG (BWLPG.OL)
31.1% sales growth and 20.16% return on equity
BW LPG Limited, an investment holding company, engages in shipowning and chartering activities worldwide. The company operates through Shipping and Product Services segments. It is involved in the transportation of liquefied petroleum gas to oil companies, and trading and utility companies. The company also offers integrated liquified petroleum gas (LPG) delivery services directly to buyers and receivers. It owns and operates LPG vessels and a fleet of very large gas carriers. The company was formerly known as BW Gas LPG Holding Limited and changed its name to BW LPG Limited in September 2013. BW LPG Limited was founded in 1935 and is headquartered in Singapore.
Earnings Per Share
As for profitability, BW LPG has a trailing twelve months EPS of kr23.72.
PE Ratio
BW LPG has a trailing twelve months price to earnings ratio of 5.31. Meaning, the purchaser of the share is investing kr5.31 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 20.16%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
BW LPG’s EBITDA is 79.74.
More news about BW LPG.
4. VERALLIA (VRLA.PA)
19.7% sales growth and 38.09% return on equity
Verallia Société Anonyme produces and sells glass packaging products for beverages and food industry worldwide. It also provides bottles for still and sparkling wines, spirits, beers, soft drinks, and oils. The company offers jars for baby food, dairy products, jams, honey, spreads, condiments, sauces, and preserves. Verallia Société Anonyme was founded in 1827 and is based in Courbevoie, France.
Earnings Per Share
As for profitability, VERALLIA has a trailing twelve months EPS of €4.08.
PE Ratio
VERALLIA has a trailing twelve months price to earnings ratio of 10.29. Meaning, the purchaser of the share is investing €10.29 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 38.09%.
More news about VERALLIA.
5. NAVAMEDIC (NAVA.OL)
17.3% sales growth and 10.19% return on equity
Navamedic ASA, a pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Northern Europe. The company's product portfolio includes prescription and non-prescription pharmaceuticals, as well as medical nutrition products, medical devices, food supplements, and cosmetics. It offers medical nutrition products for various therapeutic areas, including phenylketonuria, homocystinuria, maple syrup urine disease, tyrosinemia, methylmalonic acidemia/propionic acidemia, glutaric aciduria, isovaleric acidemia, and urea cycle disorders, as well as products for glycogen storage diseases and renal diseases, fat metabolism, malnutrition, and ketogenic diet. In addition, the company provides consumer health products consisting of non-prescription drugs and health care products for pain relief, cough and cold, gastro, obesity, women's health, and others primarily through pharmacies and drugstores; specialty pharmaceutical products in various therapeutic areas comprising dermatology, wound care, urology, and obesity; and branded generics, including cardiology products and antibiotics. It sells, markets, and distributes its products to hospitals, patients, and pharmacies. The company was formerly known as Glucomed AS and changed its name to Navamedic ASA in 2004. Navamedic ASA was incorporated in 2002 and is headquartered in Oslo, Norway.
Earnings Per Share
As for profitability, NAVAMEDIC has a trailing twelve months EPS of kr1.15.
PE Ratio
NAVAMEDIC has a trailing twelve months price to earnings ratio of 28. Meaning, the purchaser of the share is investing kr28 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.19%.
Sales Growth
NAVAMEDIC’s sales growth is 22.8% for the present quarter and 17.3% for the next.
Moving Average
NAVAMEDIC’s worth is way under its 50-day moving average of kr36.69 and way under its 200-day moving average of kr36.39.
Yearly Top and Bottom Value
NAVAMEDIC’s stock is valued at kr32.20 at 22:20 EST, way under its 52-week high of kr43.60 and way above its 52-week low of kr29.20.
More news about NAVAMEDIC.
